Evidence map›Paper›PMID 39039899›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2024

Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis.

Pamela F Weiss, Timothy G Brandon, Amita Aggarwal, Ruben Burgos-Vargas, Robert A Colbert, Gerd Horneff, Ronald M Laxer, Kirsten Minden, Angelo Ravelli, Nicolino Ruperto and 22 more

Abstract readValidation Study
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Defining axial involvement in juvenile SpA.Nature reviews. Rheumatology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Pamela F WeissChildren's Hospital of Philadelphia and University of Pennsylvania.ORCID https://orcid.org/0000-0002-9724-0443
Timothy G BrandonChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID https://orcid.org/0000-0002-1305-4871
Amita AggarwalSanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0002-2187-5186
Ruben Burgos-VargasHospital General de Mexico Dr Eduardo Liceaga, Mexico.ORCID https://orcid.org/0000-0003-1058-8955
Robert A ColbertNational Institute of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, Maryland.ORCID https://orcid.org/0000-0001-6237-4575
Gerd HorneffAsklepios Klinik Sankt Augustin, Sankt Augustin, and University Hospital Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0001-5491-7832
Ronald M LaxerUniversity of Toronto, The Hospital for Sick Children, and St. Michael's Hospital, Toronto, Ontario, Canada.
Kirsten MindenCharité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Deutsches Rheuma-Forschungszentrum, Berlin, Germany.ORCID https://orcid.org/0000-0003-2775-0111
Angelo RavelliIRCCS Istituto Giannina Gaslini and Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, Genoa, Italy.ORCID https://orcid.org/0000-0001-9658-0385
Nicolino RupertoIRCCS Istituto Giannina Gaslini, UOC Servizio Sperimentazioni Cliniche Pediatriche/Gaslini Trial Centre, PRINTO, Genoa, Italy.ORCID https://orcid.org/0000-0001-8407-7782
Judith A SmithUniversity of Wisconsin-Madison.
Matthew L StollUniversity of Alabama at Birmingham.
Shirley M TseThe Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-3027-7866
Filip Van den BoschGhent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0002-3561-5932
Walter P MaksymowychUniversity of Alberta and CARE Arthritis, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0002-1291-1755
Robert G LambertUniversity of Alberta, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0003-0305-3290
David M BikoChildren's Hospital of Philadelphia and University of Pennsylvania.
Nancy A ChauvinPenn State Health Milton S. Hershey Children's Hospital, Hershey, Pennsylvania.
Michael L FrancavillaUniversity of South Alabama, Mobile.ORCID https://orcid.org/0000-0003-1347-7097
Jacob L JaremkoUniversity of Alberta, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0001-5314-2297
Nele HerregodsGhent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0003-0244-0168
Ozgur KasapcopurIstanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-1125-7720
Mehmet YildizIstanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-7834-4909
Hemalatha SrinivasaluGeorge Washington University School of Medicine, Washington, DC, and National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.ORCID https://orcid.org/0000-0001-6714-4170
Daniel J LovellCincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.ORCID https://orcid.org/0000-0003-1604-0130
Peter A NigrovicBoston Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID https://orcid.org/0000-0002-2126-3702
Ivan FoeldvariHamburg Center for Paediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany.ORCID https://orcid.org/0000-0003-0659-5298
Marisa S Klein-GitelmanNorthwestern University Feinberg School of Medicine and Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Seza OzenHacettepe University, Ankara, Turkey.ORCID https://orcid.org/0000-0003-2883-7868
Ray Naden
Alison M HendryCounties Manukau District Health Board, Auckland, New Zealand.
Rik JoosUniversity Hospital Ghent, Ghent, and Ziekenhuisnetwerk Antwerpen, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-6087-3861

Funding

Pathogenic Mechanisms in SpondyloarthritisZIAAR041184 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$47.6M
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
Bridging the gap between GWAS and mechanism in JIAR01AR073201 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic · 2019 to 2026
$3.2M
Refining entry criteria and outcome measures for children with axial disease and spondyloarthritis: preparation for clinical trialsR01AR074098 · NIAMS · CHILDREN'S HOSP OF PHILADELPHIA · PI WEISS, PAMELA FITCH · 2019 to 2021
$678k
Intramural NIH HHS ZIA AR041184NIAMS NIH HHS 1R01AR074098NIAMS NIH HHS AR041184NIAMS NIH HHS P30 AR070253NIAMS NIH HHS P30AR070253NIAMS NIH HHS R01 AR073201NIAMS NIH HHS R01AR073201NIAMS NIH HHS R01 AR074098
6 · The paper itself

Abstract

objectiveThe goal was to develop and validate classification criteria for axial juvenile spondyloarthritis (SpA; AxJSpA).

methodsThis international initiative consisted of four phases: (1) item generation, (2) item reduction, (3) criteria development, and (4) validation of the AxJSpA criteria by an independent team of experts in an internationally representative validation cohort.

resultsThese criteria are intended to be used on youth with a physician diagnosis of juvenile SpA and for whom axial disease is suspected. Item generation consisted of a systematic literature review and a free-listing exercise using input from international physicians, which collectively resulted in 108 items. After the item reduction exercise and expert panel input, 37 items remained for further consideration. The final AxJSpA criteria domains included the following: imaging of active inflammation, imaging of structural lesions, pain chronicity, pain pattern, pain location, stiffness, and genetics. The most heavily weighted domains were active inflammation and structural lesions on imaging. Imaging typical of sacroiliitis was deemed necessary, but not sufficient, to classify a youth with AxJSpA. The threshold for classification of AxJSpA was a score of ≥55 (out of 100). When tested in the validation data set, the final criteria had a specificity of 97.5% (95% confidence interval [CI] 91.4%-99.7%), sensitivity of 64.3% (95% CI 54.9%-73.1%), and area under the receiver operating characteristic curve of 0.81 (95% CI 0.76%-0.86%).

conclusionThe new AxJSpA classification criteria require an entry criterion and a physician diagnosis of juvenile SpA and include seven weighted domains. The AxJSpA classification criteria are validated and designed to identify participants for research studies.

Indexed as

Axial SpondyloarthritisAdolescentArthritis, JuvenileChildFemaleHumansMaleSacroiliitisSpondylarthritis

Identifiers

PMID39039899
PMCPMC11606790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.